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Abstract
Objective-To examine the role of serum
cholesterol in acute myocardial infarc-
tion in a population of patients with no
history of coronary heart disease and to
establish the nature of this association,
the degree of risk, and the possible inter-
action between serum cholesterol and
other major risk factors for acute
myocardial infarction.
Design-Case-control study.
Setting-90 hospitals in northern, cen-
tral, and southern Italy.
Patients-916 consecutive cases of newly
diagnosed acute myocardial infarction
and 1106 hospital controls admitted to
hospital with acute conditions not related
to known or suspected risk factors for
coronary heart disease.
Data collection-Data were collected with
a structured questionnaire and blood
samples were taken by venepuncture as
soon as possible after admission to hospi-
tal from cases and controls. Blood cho-
lesterol concentrations were available for
614 cases and 792 controls.
Results-After adjustment by logistic
regression for sex, age, education, geo-
graphical area, smoking status, body
mass index, history of diabetes and
hypertension, and family history of coro-
nary heart disease the estimated relative
risks of acute myocardial infarction for
quintiles of serum cholesterol (from low-
est to highest) were 2'3 (95% confidence
interval (CI) 16 to 3.4), 3-1 (95% CI 2-1 to
4.6), 4-1 (95% CI 2-8 to 6.0), and 5 2 (95%
CI 3 5 to 7.7). The estimated relative risk
across selected covariates increased from
the lowest to the highest quintile of
serum cholesterol particularly for men,
patients under 55 years of age, and smok-
ers. When the possible interaction of
known risk factors with serum choles-
terol was examined, smoking habits,
diabetes, and hypertension had approxi-
mately multiplicative effects on relative risk.
Conclusions-This study indicates that
serum cholesterol was an independent
risk factor for acute myocardial infarc-
tion. This association was linear, with no
threshold level. Moreover, there was a
multiplicative effect between cholesterol
and other major risk factors on the rela-
tive risk of acute myocardial infarction.
(Br Heart J 1994;71:468-473)
Epidemiologists and clinicians continue to
debate which interventions aimed at reducing
the most common risk factors in coronary
heart disease are most effective in primary
prevention. 1-6 Epidemiological studies have
established a positive association between
blood cholesterol concentrations and coro-
nary heart disease. According to the classic
"lipid hypothesis" there is a strong correlation
between high concentrations of serum choles-
terol and development of atherosclerosis and
subsequently the occurrence of clinical mani-
festations of coronary heart disease.7-'0
Some policy statements for clinical guide-
lines suggest that there are threshold concen-
trations of serum cholesterol below which the
risk of coronary heart disease is lower. 11-14
A large observational population study
(Multiple Risk Factors Intervention Trial,
MRFIT), however, suggested that the risk of
coronary heart disease is strong, and increases
linearly with serum cholesterol concentration.'5
The incidence of and mortality from coro-
nary heart disease and acute myocardial
infarction in each country varies with the
mean serum cholesterol concentration for that
country.16-18 In populations with higher mean
concentrations (such as those in North
Europe and North America) coronary heart
disease is responsible for more than half of all
deaths. 19-22 In other countries, such as Japan,
some Mediterranean regions, and most devel-
oping countries, lower mean serum choles-
terol concentrations are associated with a
lower incidence of and mortality from coro-
nary heart disease.2'-26 Moreover, within some
countries risk profiles for coronary heart dis-
ease and particularly for acute myocardial
infarction are different in areas where lifestyle
habits (diet, physical activity, behaviour
pattern) are different.27-30 This may be true of
Italy.
We have examined the relation between
cholesterol and acute myocardial infarction in
patients without a history of coronary heart
disease. The present large case-control study
was designed to control for several other
major risk factors for coronary heart disease.
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Patients and methods
This case-control study was conducted
between September 1988 and June 1989
within the hospital network of the GISSI-2
study (Gruppo Italiano per lo Studio della
Sopravvivenza nell'Infarto), a randomised
controlled clinical trial including 12 490 cases
of acute myocardial infarction that was
designed to assess the risk/benefit profile of
streptokinase and alteplase (and of their pos-
sible association with heparin) in the treat-
ment of acute myocardial infarction.3'
Ninety hospitals, in northern, central, and
southern Italy that took part in the GISSI-2
trial were enrolled in this case-control study.
There were 916 patients (801 men and
115 women, median age 57, range 24-74)
under 75 years of age consecutively admitted
to hospital for a confirmed episode of acute
myocardial infarction, without a history of
ischaemic heart disease who conformed with
the GISSI-2 criteria.3'
The controls were patients under 75 years
of age admitted to the same hospitals as the
cases. They had acute conditions not related
to known or potential risk factors for acute
myocardial infarction. Patients with history of
ischaemic heart disease or admitted for
cardio-cerebrovascular, neoplastic, or any
other chronic diseases were excluded from
the control group. The control group con-
sisted of 1106 patients (976 men and 130
women median age 57 years, range 23-74)
with similar distributions of sex age, and hos-
pital admission. They had been admitted with
injuries (mostly fractures and sprains (40%);
with non-traumatic orthopaedic disorders
(mostly low back pain and intervertebral disc
disorders) (15%); for surgery (including plas-
tic surgery (25%); and with other illnesses
such as acute infections or skin, ear, nose,
and throat disorders (20%).
A cardiologist at each hospital selected
patients and collected, by a structured ques-
tionnaire, data on personal and sociodemo-
graphic characteristics, lifestyle habits (such
as smoking, consumption of alcohol and of
coffee and other beverages containing
methylxanthine, physical activity, and pres-
ence of a network of social relationships),
medical history of selected diseases, family
history of cardiovascular diseases, and, for
women, gynaecological and obstetric data.
The presence of diabetes, hypertension, and
hyperlipidaemia was recorded if the patient
was being treated or had a clinical record of
the condition. All interviewers were trained
and checked for reliability and consistency.
The reproducibility, and hence the reliability,
of different sections of the questionnaire var-
ied. It was low for social networks but satis-
factory (t >0.8) for sociodemographic factors,
smoking, medical history, and family history
of cardiovascular diseases.
Blood samples were taken from cases and
controls by venepuncture as soon as possible
after admission to hospital. Fasting total
serum cholesterol concentrations were mea-
sured by the standard method available in
Italian hospital laboratories. Serum choles-
terol concentrations were reported for 614
cases (542 men and 72 women) aged 24-74
years (median age 56-5 years) and for 792
controls (705 men and 87 women) aged 23 to
74 years (median age 56 3). Those patients
who were excluded from the study because
fasting total serum cholesterol was not avail-
able, resembled those who were included.
Statistical analysis
We computed the odds ratios, as estimators
of relative risks (RR) of acute myocardial
infarction, with their 95% confidence inter-
vals (CI) by the Mantel-Haenszel procedure32
for quintiles of the distribution of serum cho-
lesterol. The significance of the linear trends
in risk was assessed by the x2 test described
by Mantel.32 Further, the potential reciprocal
confounding effects of sex, age, years of edu-
cation, geographic area (north, central, and
southern Italy), cigarette smoking (never, ex,
current), body mass index (Quetelet's index
(QI = kg/M2)), history of diabetes and hyper-
tension, and family history of coronary heart
disease were controlled for by unconditional
multiple logistic regression.
On the basis of multivariate RR estimates,
attributable risk (AR) was computed by the
method of Bruzzi et al,35 which provides a
Table 1 Distribution of 614 cases of acute myocardial
infarction and 792 controls according to socioeconomic and
clinical variables
Cases Controls
Variables n % n %
Sex:
Male 542 88-3 705 89-0
Female 72 11-7 87 11-0
Age (yr):
<45 76 12-4 118 14 9
45-54 160 26-1 194 24-5
55-64 231 37.6 289 36-5
65-74 147 23-9 191 24.1
Years of education:
<_ 7 329 54 0 543 69-3
7-11 174 28.6 157 20-0
12 106 17-4 84 10 7
Geographical area:
North 206 34.4 266 34 2
Central 127 212 181 23 3
South 265 44-3 311 42-5
Smoking habits
Never smokers 98 16-0 227 28-9
Exsmokers 94 15-3 168 21 3
Current smokers
<20 133 21-7 156 199
-20 289 47 0 235 29-9
Coffee consumption
(cups/day):
0-1 165 26-9 355 44 8
2-4 350 570 387 48 9
,_5 99 16-1 50 6-3
Body mass index (BMI)*:
<25 206 33-6 350 44-2
25-30 322 52-4 358 45-2
>30 86 14 0 84 10-6
Hypertension:
No 438 71-3 655 82 7
Yes 176 28-7 137 17 3
Diabetes mellitus:
No 542 88-3 729 92-0
Yes 72 11-7 63 8 0
Family history:
AMI in at least 1
relative 138 22-5 79 10-0
AMI in at least 2
relatives 23 3-7 12 1-5
* Quetelet's index: weight in kg/height in metres.2 Small dis-
crepancies in the totals are explained by lack of some informa-
tion in a few patients.
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Table 2 Distribution of 614 cases of acute myocardial
infarction and 792 controls according to quintiles of serum
cholesterol
Cases Controls
Quintiles
(mgldl) n % n %
< 171 66 10-7 228 28.8
171-195 109 17 8 173 21 8
196-219 130 212 155 196
220-249 146 23-8 126 15 9
s250 163 26-5 110 13 9
Table 3 Relative risks (and 95% confidence intervals) of
acute myocardial infarction according to quintiles of serum
cholesterol
Relative risk
Quintiles
(mg/dl) MLRa MLRb
< 171 1 1
171-195 2-2 2-3
(1-5 to 32) (1 6 to 34)
196-219 2-9 3 1
(2-0 to 42) (2-1 to 46)
220-249 4-2 4 1
(29 to 60) (28 to 60)
)250 54 52
(3-7 to 78) (35 to 7-7)
x21 trend 98-07 78.66*
(a) Estimates adjusted for sex, age, and geographic area. (b)
Multiple logistic regression includes terms for sex, age, years
of education, geographic area, cigarette smoking, body mass
index, history of diabetes and hypertension, and family history
of CHD.
* p < 0 001.
summary attributable risk for multiple factors
after allowance for confounding. The method
requires information on only the joint distrib-
ution of the risk factors among cases and on
the adjusted RR associated with each factor.
Provided that unbiased RR estimates are
obtained and that the cases can be assumed
to be representative of all cases in the popula-
tion in terms of exposure distribution, this
method can be applied to data from hospital
based case-control studies. Whenever risk
factors are not mutually exclusive, their com-
bined attributable risk will differ from the
simple sum of the attributable risks for each
factor.35
Results
Cases and controls had similar age, sex, and
geographical distributions (table 1). Cases of
acute myocardial infarction tended to be
more educated than controls and a higher
proportion were smokers and coffee drinkers.
Cases were more frequently obese, with a
Quetelet's index (QI) over 25. Similarly, dia-
betes (11-7% of cases of acute myocardial
infarction and 8-0% of controls), hyperten-
sion (28&7% of cases of acute myocardial
infarction and 17-3% of controls), and posi-
tive family history of coronary heart disease
(26-2% of cases of acute myocardial infarc-
tion and 11-5% of controls) were more com-
mon in the acute myocardial infarction
group.
Table 2 shows the distribution of cases and
controls according to quintiles of serum cho-
lesterol. There were more cases in the higher
cholesterol quintiles. In fact, only 11% of the
cases compared with 29% of the controls had
serum cholesterol below 171 mg/dl (mmol/l
4 43) and 71-5% of the cases of acute
myocardial infarction had concentrations
above 196 mg/dl (5 07 mmol/l) compared
with 49 4% of controls.
The relative risk of acute myocardial
infarction increased from 2-3 (95% CI 1 *6 to
3-4) in the second quintile to 3-1 (95% CI
2-1 to 4 6) in the third, to 4-1 (95% CI 2-8 to
6-0) in the fourth, and to 5.2 (95% CI 3*5 to
7'7) in the group with highest values (table
3).
Table 4 shows the relative risks of acute
myocardial infarction and the estimates of the
X2 for linear trend test according to quintiles
of serum cholesterol in separate strata of
selected covariates. With all the variables that
were taken into account there was an increas-
ing relative risk and a significant linear trend
with increasing concentrations of serum cho-
lesterol. In men the estimated risk was 2-2 in
the lowest quintile and 3-2, 4.3, 4-9 for sub-
sequent quintiles, with a statistically signifi-
cant linear trend in risk. The risk of acute
myocardial infarction in the highest quintile
was more than ninefold that of the lowest one
for subjects under 55 years of age, with a sig-
nificant linear trend (X2 trend = 57X86). In the
older age group the increase in risk was three
times that of the lowest quintile, with a signif-
icant linear trend (X2 trend = 26-13). The
association of serum cholesterol with acute
myocardial infarction was also consistent
among strata of smoking.
For some variables, the association
between serum cholesterol and acute myocar-
dial infarction was apparently stronger in the
high risk strata (that is, among smokers,
heavy coffee drinkers, and overweight sub-
jects). The risk estimates were particularly
high in very obese patients: in the two highest
quintiles of serum cholesterol the RR was
increased 20-fold.
To analyse the effect of interactions, rela-
tive risks were computed for cholesterol when
other major risk factors for acute myocardial
infarction were present (table 5). In those
with a cholesterol concentration higher than
200 mg/dl (5X18 mmol/l) who were current
smokers the relative risk was 7-6 (95% CI 3-8
to 15-3). For those smokers with a fasting
serum cholesterol of >200 mg/dl (5 18
mmol/l) and with history of diabetes mellitus
the relative risk was 4-3 (95% CI 2-5 to 7 5).
For patients with high serum cholesterol con-
centrations and history of hypertension the
relative risk was 5*0 (95% CI 3-4 to 7 3).
Discussion
This case-control study confirms and further
quantifies a positive association between
serum cholesterol concentration and risk of
acute myocardial infarction in a Western pop-
ulation with a low mean serum cholesterol
concentration. Even a moderately high serum
cholesterol concentration increased the risk of
acute myocardial infarction developing.
These results provide convincing evidence
that there is no threshold effect. This associa-
tion was linear and was not materially
changed when allowance was made for
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Table 4 Estimated relative risk (95% confidence intervals) of acute myocardial infarction according to quintiles ofserum
cholesterol (mgldl) in separated strata ofselected covariates
Variables < 171 171-195 196-219 220-249 >250 Cases x2 trend
Sex
Male
Female
Age (y)
<55
>55
Years of education
<7
7-11
,12
Geographical area:
North
Central
South
Smoling habits:
Never smokers
Ex smokers
<20
,20
Coffee consumption
(cups/day):
0-1
2-4
,5
Body mass index (kg/M2)
<25
25-30
>30
Hypertension:
Yes
No
Diabetes:
Yes
No
Positive family history
AMI in at least 1
relative
1 2-2
(1-5 to 3-3)
1 4-3
(1 1 to 16-4)
1 2-2
(10 to 46)
1 2-4
(1-5 to 3 8)
1 3-1
(1 9 to 5-1)
1 1-2
(0-5 to 2 6)
1 2-1
(07 to 6.8)
1 2-7
(1-3 to 5.8)
1 2-6
(1 1to 64)
1 2-2
(1-2 to 37)
1 3-2
(1*2 to 8 7)
1 09
(04 to 2.2)
1 1-3
(0-5 to 3-1)
1 3-6
(19 to 6-6)
1 2-6
(1-3 to 5-1)
1 2-0
(1*2 to 3 4)
1 2-3
(0-6 to 9-4)
1 1-7
(1-0 to 3-0)
1 2-6
(1-4 to 4-7)
1 7-2
(1-7 to 30-3)
1 1-6
(0 7 to 3 7)
1 04
(0 3 to 1-5)
1 9-6
(2-3 to 40 0)
1 05
(03 to 08)
1 30
(1 0 to 8-6)
3-2
(2-1 to 4 7)
2-9
(09 to 109)
4-5
(2-2 to 9-0)
2-5
(1*6 to 4-1)
3-4
(2-1 to 5 5)
1-9
(0-8 to 4 2)
5-1
(1-7 to 15-4)
40
(19 to 86)
2-5
(1 1 to 5 7)
2-9
(1-7 to 5-1)
4-8
(1-8 to 12-7)
1-8
(0 7 to 4 5)
2-1
(0 9 to 5-1)
3-8
(2-1 to 7-0)
2-4
(1-2 to 4-8)
3-4
(2-0 to 5 7)
4-4
(0-9 to 21-1)
2-2
(1-2 to 4- 1)
3-4
(2-0 to 6 0)9.9
(2-4 to 40-0)
1-8
(0-8 to 4- 1)
1-5
(10 to 23)
11-3
(2-6 to 491)
1-5
(10 to 22)
2-5
(0-9 to 6 9)
4-3
(2-9 to 6-5)
2-5
(0-6 to 10-6)
8-1
(3-9 to 16-5)
2-7
(1-7 to 4-4)
3-8
(2-3 to 6 2)
2-9
(1-3 to 6 3)
14-0
(4-2 to 46-4)
5-8
(2-8 to 12-1)
2-0
(0-9 to 4-5)
5-2
(2-9 to 9-4)
6-1
(2-3 to 17-9)
2-0
(0-8 to 5-1)
2-9
(1-2 to 7 0)
5-8
(3-1 to 10-7)
40
(2-0 to 79)
4-1
(2-4 to 7-0)
3-3
(0-8 to 13-4)
2-5
(1-3 to 4-7)
4-4
(2-5 to 7-9)
22-0
(5-2 to 93 5)
2-6
(1-1 to 6.0)
1-9
(1-3 to 2 9)
15-1
(2-6 to 88-0)
2-0
(1-4 to 2 9)
3-7
(1-3 to 10-3)
4.9
(3-2 to 7-4)
8-6
(2-2 to 33-1)
9.5
(47 to 19-3)
3-7
(2-3 to 6-0)
5-5
(3 3 to 9 2)
30
(1-3 to 6 7)
12-0
(3-7 to 38-7)
6-6
(3-1 to 13-8)3.9
(1-7 to 8 9)
5-0
(2-7 to 9 1)
7-8
(2-9 to 21- 1)
2-2
(0-8 to 5 6)
4-4
(1-7 to 11-4)
6-2
(3-4 to 11-6)
4-5
(2-2 to 93)4.9
(2-9 to 8 2)
5-6
(1-4 to 22 8)
6-3
(3-2 to 12-5)
4-1
(2-3 to 7-1)
26-3
(6-4 to 109-0)
3-0
(1-3 to 6-7)
2-1
(1-4 to 33)
6-6
(1-5 to 29-5)
2-5
(1-7 to 3-7)
2-9
(1 1to 77)
542 70 37*
72 7 161t
236
378
57-86*
26- 13*
329 41-23*
174 11-87*
106 29-47*
206
127
265
98
94
133
289
31-36*
6-95 t
39-25*
19-46*
5-091t
12-59*
38- 12*
165 19-90*
350 43.40*
99 5-55t
209
322
86
28-65*
27-32*
27- 12*
176 8-31t
438 36-05*
72
542
4-18t
47-45*
79 3-81
Estimates from multiple logistic regression models including terms for sex, age, years of education, geographic area, cigarette
smoking, body mass index, history of diabetes and hypertension, and family history of CHD (whenever appropriate).
* p < 0-001, 1p < 0-01, p<005.
Table S Relative risks (and 95% confidence intervals)
for interaction between serum cholesterol and other selected
risk factors for acute myocardial infarction
Relative risk (MLRa)
Variables < 200 mg/dl 200 mgldl
Smoking habits:
Never smokers 1 2-5 (1-4 to 4 2)
Ex smokers 1-5 (0-8 to 2-9) 3-2 (1-8 to 5-7)
Current smokers 2-8 (1-7 to 4-6) 7-6 (3-8 to 15-3)
Diabetes:
No 1 2-6 (2-0 to 3 4)
Yes 2-2 (1-2 to 3 9) 4-3 (2-5 to 7 5)
Hypertension:
No 1 2-6 (2-0to 3-4)
Yes 2-1 (1-3 to 33) 50 (34to 73)
(a) Multiple logistic regression includes terms for sex, age,
years of education, geographic area, cigarette smoking, body.
mass index, history of diabetes and hypertension, and family
history of CHD.
several risk factors. There was a positive lin-
ear trend within each stratum for every
covariate that we examined.
Several risk factors for acute myocardial
infarction have been repeatedly and strongly
correlated in various observational studies:3"0
in addition to total serum cholesterol these
were cigarette smoking, obesity, raised blood
pressure, and diabetes mellitus. The mecha-
nism of the effect of cholesterol on the risk of
acute myocardial infarction is likely to be
independent of those of smoking, diabetes,
and hypertension. In fact, particularly for
smoking, the combined risk estimated for
exposure to the two factors was consistent
with the multiplicative effect of interaction on
the relative risk.
A major strength of this study lies in the
accuracy of the criteria for diagrnosis; of acute
myocardial infarction and in the exclusion
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from the analysis of the subjects in whom a
history of coronary heart disease could have
led to modifications in lifestyle habits.
A possible weakness of this study is the
exclusion of fatal cases of acute myocardial
infarction. We analysed data from only the
patients with acute myocardial infarction who
lived long enough to be interviewed. None
the less, the association between serum cho-
lesterol concentration and acute myocardial
infarction was seen in other studies14 41-42 both
for fatal and non-fatal acute myocardial
infarction.
The choice of hospital controls could be
criticised as not being representative of the
general population and as introducing selec-
tion bias. We carefully considered patients
admitted to the same hospitals as the cases.
They had various acute diseases not related
to known or potential risk factors for acute
myocardial infarction so that they were typi-
cal of the same population as the cases. The
distribution in each hospital of age, sex and
geographic area was similar for cases and
controls. A further advantage of using hospi-
tal controls is that the quality of information
is the same as for the cases, because both
groups had been ill and admitted to hospital.
Case-control studies provide accurate infor-
mation on the role of recent exposure because
they avoid the interval between data collec-
tion and the occurrence of acute myocardial
infarction, which might dilute the strength of
relation.
The measurement of total serum choles-
terol rather than various lipoproteins could be
regarded as a limitation of this study.
Nevertheless the observation of a strong and
consistent relation with such an overall mea-
sure as total cholesterol is of specific interest,
because it indicates that even one simple
measurement is a strong predictor of subse-
quent myocardial infarction. Among the
other strengths of the study was the fact that
blood samples were taken as quickly as possi-
ble after the admission to hospital of cases
and controls. This procedure was applied in
each category of patients and did not influ-
ence the accuracy of measurement. The lipid
and cholesterol state of the patients can be
assessed accurately in the first 48 hours after
an acute myocardial infarction.4' Also the sin-
gle serum cholesterol measurement on which
analyses were based does not represent a
methodological problem because the random
error to which a single measurement is sub-
ject could at most produce a systematic
underestimation of the real association
between the usual cholesterol concentration
and disease.44
In Italy mean cholesterol concentration
and the risk of acute myocardial infarction are
lower than in most Northern European and
American populations and higher than in
Asian and in developing countries. In our
study mean total serum cholesterol was 223-4
(SD 46 6) (5-8 mmol/l) in the cases and
198-8 (SD 49-2) (5-2 mmol/l) in the controls.
Populations with lower concentrations of
cholesterol also have lower rates of coronary
heart disease. The population with the high-
est concentration of serum cholesterol (East
Finland, median total serum cholesterol =
6-6 mmol/l) has a death rate from coronary
heart disease 15 times that of the population
with the lowest serum cholesterol (Japan,
median total serum cholesterol = 4-1
mmoI/1).45
The continuous linear association that we
found is consistent with the results of the
Multiple Risk Factor Intervention Trial study
(MRFIT), which showed a linear relation
between serum cholesterol concentration and
coronary heart disease. Moreover, the linear
increment in coronary heart disease rates for
a given increment in serum cholesterol was
larger at higher concentrations of serum cho-
lesterol. This linear trend was apparent for
serum cholesterol concentrations that were
lower than those generally considered as safe
in Western populations.2'
The different sex and age risk profiles for
acute myocardial infarction in our study
accord with data from many other epidemio-
logical studies.45 In the Donolo-Tel Aviv
Prospective Coronary Artery Disease Study46
the incidence of definite coronary events
increased from 6% in men with total choles-
terol concentrations below 200 mg/dl (5 18
mmol/l) to 25% in men with concentrations
above 264 mg/dl (6-84 mmol/l). The corre-
sponding figures in women were 3% and
10%. Gender and age do influence the extent
to which total cholesterol and other risk fac-
tors can be linked to rates of coronary heart
disease. Data from the Framingham study
showed that the coronary heart disease rates
among women with total cholesterol above
6-9 mmol/l are lower than among men with
values in the normal range.47 In this study the
relation between serum cholesterol and
myocardial infarction was stronger at younger
ages, though the association was also present
in the elderly.
The Framingham Study showed that in
subjects aged ) 60 the relative risk of coro-
nary heart disease was reduced by decreasing
serum cholesterol concentrations.4' 48A9 In
contrast, 12 years of follow-up data from the
Honolulu Heart Program showed no decrease
in the relative risk of coronary heart disease
between the first and the fourth quartiles of
total serum cholesterol when fatal and non-
fatal events were compared in men aged
52-59 and 65-74.5°
In terms of attributable risks, our study
suggests that 58% of first episodes of acute
myocardial infarction in this population could
have been avoided by reducing serum choles-
terol below 196 mg/dl (5 07 mmol/l) and that
45% would have been avoided by decreasing
the serum cholesterol of patients in each
quintile to the respective lower quintile.
In conclusion, these results confirm that
serum cholesterol is an important risk factor
for acute myocardial infarction and that pre-
ventive measures are needed.
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